About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,587 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,587 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2721-2740 of 6,587 trials

CompletedStudy of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell LymphomaThis is a randomized, open-label, multicenter, prospective study to compare the efficacy and safety of the combination of VcR-CAP to that of R-CHOP in participants who have newly…NCT00722137·Hartford, Connecticut and 149 others

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

CompletedHaploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerThis phase II trial studies how well giving fludarabine phosphate, cyclophosphamide, tacrolimus, mycophenolate mofetil and total-body irradiation together with a donor bone marrow…NCT00049504·Seattle, Washington

CompletedRituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell LymphomaRATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritumomab tiuxetan, can locate cancer cells and either kill them or deliver radioactive cancer-killing…NCT00070447·Birmingham, Alabama and 86 others

CompletedA Study of LP-118 in Patients With Advanced TumorsThis is a phase I, multi-center, open-label, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and clinical activity of LP-118 in patients with advanced…NCT05025358·Guangzhou, Guangdong and 3 others

TerminatedA Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell LymphomaThis study will look at whether brentuximab vedotin works and is safe in the re-treatment setting.NCT03947255·Anaheim, California and 18 others

Active not recruitingStudy of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL).NCT04662255·Anchorage, Alaska and 188 others

CompletedReduced Radiation in Patients With Diffuse Large B-cell LymphomaThis study will evaluate whether a reduction in the radiation dose and field size will maintain a high rate of local control while minimizing the risk of acute and late toxicity.NCT01186978·Durham, North Carolina and 2 others

Not yet recruitingZanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial RemissionThis single-arm, prospective clinical study will evaluate the efficacy and safety of Zanubrutinib-based maintenance therapy for post-remission in newly diagnosed DLBCL who are…NCT06669143

Active not recruitingA Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin LymphomaThis study will evaluate the safety, efficacy, and pharmacokinetics of mosunetuzumab or glofitamab in combination with CELMoDs (CC-220 and/or CC-99282) in participants with B-cell…NCT05169515·San Francisco, California and 24 others

CompletedVorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's LymphomaThis phase II trial studies how well giving vorinostat, cladribine, and rituximab together works in treating patients with mantle cell lymphoma (MCL), chronic lymphocytic leukemia…NCT00764517·Portland, Oregon and 1 other

CompletedMelphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerRATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarabine, and a monoclonal antibody, such as alemtuzumab, before a donor bone marrow or peripheral blood stem…NCT00027560·New York, New York

CompletedCyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00002501·Chicago, Illinois and 14 others

Not yet recruitingDevelopment of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.Observational, single-center, tissue-based cohort study involving both retrospective and prospective enrollment of patients undergoing CAR-T cell therapy and up to 1 year of…NCT06720701·Bologna, Bologna

CompletedDonor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid CancerRATIONALE: Drugs used in chemotherapy, such as melphalan, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.NCT00248430·Seattle, Washington and 1 other

TerminatedBiodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis FungoidesThis is a single-arm, non-randomized feasibility study designed to find out if the laser light-based imaging test called Biodynamic imaging (BDI) can correctly predict the…NCT03789864·Indianapolis, Indiana

RecruitingChidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOPTo evaluate the efficacy and safety of chidamide monotherapy as maintenance treatment in patients with diffuse large B-cell lymphoma (DLBCL) and HBV infection following initial…NCT07493109·Changchun, Jilin

TerminatedStudy of Repeat Intranodal Injections of Ad-ISF35This is a Phase II, open label, fixed dose, repeat injection, single institution study.NCT00942409·La Jolla, California

CompletedEarly On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IVEarly identification of refractory lymphoma patients provides a basis for stratification between responders to standard approaches and non-responders who may benefit from an early…NCT00286832·Odense

RecruitingRecommendations for the Treatment of Children With Burkitt's LymphomaThis is the 4th LMB study by the French African Pediatric Oncology Group (GFAOP).NCT04425421·Ouagadougou and 6 others

RecruitingEfficacy and Safety Evaluation of U01(ssCART-19) in B-Cell LymphomaThis is an open-label phase1 study to assess the safety and efficacy of U01(ssCART-19) cell therapy in the treatment of patients with refractory or recurrent B-cell lymphoma .NCT06987916·Shanghai, Shanghai Municipality

PreviousPage 137 of 330Next